Özlem Alkan Yılmaz

Özlem Alkan Yılmaz

Auto-generated profile, based on publicly available information

Özlem Alkan Yılmaz

Ege Üniversitesi Tıp Fakültesi Fizyoloji AD

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Turkish Journal of Parasitology
Verified
Journal Article
Closed access
OZOrçun Zorbozan
Orçun Zorbozan
VEVedat Evren
Vedat Evren
MHMehmet Harman
Mehmet Harman
AÖAhmet Özbilgin
Ahmet Özbilgin
ÖYÖzlem Alkan Yılmaz
Özlem Alkan Yılmaz
NTNevin Turgay
Nevin Turgay
Because the protocols used in the treatment of leishmaniasis can be toxic and have many limitations, such as the development of resistance against such protocols, new treatment options are needed, especially against resistant patients. Ex vivo models may be a good source for evaluating new drug options for patients with antimony-resistant parasites. This study aimed to evaluate the Glucantime concentration for our ex vivo glial cell amastigote model we had defined in previous work. We prepared the astroglial cell culture from brains of 2 to 3 day old neonatal Sprague-Dawley rats under sterile conditions by modifying McCarthy's method. Four plates of cells were infected with antimony-resistant Leishmania tropica promastigotes. After 24 h of incubation, we added Glucantime to 3 plates with different concentrations. After 72 h, we removed the supernatant and then dried, fixed, and stained the plates with Giemsa to count the amastigotes in the glial cells. We observed the amastigotes in glial cells in the control flask. Glial cells were ruined in flasks, which include 75 μg/mL and 37.5 μg/mL Glucantime. The number of amastigotes per 100 glial cells was 116 for the flask with 7.5 μg/mL Glucantime concentration, while 487 for the control flask. We found that while high concentrations of Glucantime were toxic for glial cells, 7.5 μg/mL Glucantime concentration managed to reduce the number of Leishmania tropica amastigotes in glial cells.

1 August 2024 in Journal of Clinical and Analytical Medicine
Verified
Journal Article
Closed access
BGBetul Genc
Betul Genc
MCMeltem Yılmaz Cosar
Meltem Yılmaz Cosar
MEMumin Alper Erdogan
Mumin Alper Erdogan
OYOzlem Yılmaz
Ozlem Yılmaz
Aim This study investigates the neuroprotective properties of the polyphenolic compounds resveratrol and curcumin against rotenone-induced toxicity in SH-SY5Y neuronal cells. Methods The cytotoxic threshold (LD50) of rotenone was established through a dose-response assessment in SH-SY5Y cells. Cells were preincubated with varying concentrations of resveratrol (1-100 µM) and curcumin (10-1000 nM), followed by a 24-hour rotenone challenge (200 nM). Cell survival was gauged using the MTS assay, while caspase-3 levels, as a marker of apoptosis, were quantified via ELISA. The capability of cells to form colonies post-treatment was determined through a clonogenic survival assay. Moreover, the Western blot analysis revealed that pre-treatment with resveratrol and curcumin significantly modulated the protein expression levels of Bax and Bcl-2. Results Pretreatment with resveratrol and curcumin significantly enhanced cell viability and clonogenic survival in the presence of rotenone, with notable decreases in caspase-3 levels, implying reduced apoptosis (P < .05). These compounds also modulated the expression of Bax and Bcl-2, contributing to their protective effects. Conclusion Resveratrol and curcumin exhibit promising neuroprotective effects by improving cell survival and modulating apoptotic markers in SH-SY5Y cells subjected to rotenone-induced toxicity. These findings support the potential therapeutic role of these polyphenols in neurodegenerative disease management, pending further validation through comprehensive pre-clinical and clinical studies.

30 September 2026 in Journal of Basic and Clinical Health Sciences
Verified
Journal Article
Closed access
FKFerit Anıl Kocabaş
Ferit Anıl Kocabaş
MEMumin Alper Erdogan
Mumin Alper Erdogan
ÖYÖzlem Yılmaz
Özlem Yılmaz
Purpose: Rotenone induces Parkinson's disease-like neurotoxicity through mitochondrial impairment, oxidative stress, and apoptosis. We investigated the neuroprotective efficacy of boldine against rotenone-induced cytotoxicity in human SH-SY5Y neuroblastoma cells.Material and Methods: SH-SY5Y cells were pretreated with boldine (0.1–100 µM) for 2 h before exposure to 200 nM rotenone for 24 h. Cell viability, clonogenic capacity, active caspase-3 levels, and apoptotic nuclear morphology were evaluated using the MTS assay, clonogenic assay, ELISA, and Hoechst 33342 staining, respectively.Results: Rotenone (200 nM) significantly reduced viability to 32.3%, suppressed clonogenic potential (3.9%), and increased active caspase-3 levels (p